Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cluster Randomised Non-inferiority Trial Comparing Malaria Incidence When Implementing R21/Matrix-M Synchronized With Seasonal Malaria Chemoprevention Distribution Versus R21/Matrix-M Given Routinely Through the EPI in Two Health Districts in Chad (CoSAV-R21)

NCT07038837 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.

NCT NCT07038837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07038837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cluster Randomised Non-inferiority Trial Comparing Malaria Incidence When Implementing R21/Matrix-M Synchronized With Seasonal Malaria Chemoprevention Distribution Versus R21/Matrix-M Given Routinely Through the EPI in Two Health Districts in Chad (CoSAV-R21)
Lead sponsor
Epicentre
Phase
Phase 4
Overall status
Recruiting
Start date
June 16, 2025
Completion date
June 30, 2028
Enrollment
70,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria infection, malaria vaccines